FRA:YTSN - Deutsche Boerse Ag - CH0325814116 - Common Stock - Currency: EUR
FRA:YTSN (7/18/2025, 7:00:00 PM)
30.7
-0.56 (-1.79%)
The current stock price of YTSN.DE is 30.7 EUR.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
4AB.DE | ABBVIE INC | 18.53 | 288.63B | ||
AMG.DE | AMGEN INC | 14.3 | 137.04B | ||
GIS.DE | GILEAD SCIENCES INC | 14.12 | 116.61B | ||
VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 102.50B | ||
ARGX.BR | ARGENX SE | 107.19 | 30.04B | ||
22UA.DE | BIONTECH SE-ADR | N/A | 22.69B | ||
IDP.DE | BIOGEN INC | 7.99 | 15.90B | ||
0QF.DE | MODERNA INC | N/A | 10.56B | ||
1MRNA.MI | MODERNA INC | N/A | 10.54B | ||
1VKTX.MI | VIKING THERAPEUTICS INC | N/A | 3.00B | ||
GLPG.AS | GALAPAGOS NV | N/A | 1.77B | ||
5CV.DE | CUREVAC NV | 5.72 | 1.04B |
Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. The company is headquartered in Schlieren, Zuerich and currently employs 122 full-time employees. The company went IPO on 2002-10-29. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension, nicotine addiction, allergic diseases, asthma, malignant melanoma and Alzheimer's disease. They are designed to instruct the patient's immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. The firm has built a pipeline of different Immunodrug candidates, of which five are in clinical development. Its Immunodrug candidates are developed both in-house and together with Novartis, Pfizer and Pfizer Animal Health, among others. The firm has two subsidiaries: a wholly-owned Proteome Therapeutics GmbH and minority owned BioSupport AG.
KUROS BIOSCIENCES AG-REG
Wagistrasse 25
Schlieren ZUERICH CH
Employees: 122
Phone: 41447334747
The current stock price of YTSN.DE is 30.7 EUR. The price decreased by -1.79% in the last trading session.
The exchange symbol of KUROS BIOSCIENCES AG-REG is YTSN and it is listed on the Deutsche Boerse Ag exchange.
YTSN.DE stock is listed on the Deutsche Boerse Ag exchange.
KUROS BIOSCIENCES AG-REG (YTSN.DE) has a market capitalization of 1.18B EUR. This makes YTSN.DE a Small Cap stock.
KUROS BIOSCIENCES AG-REG (YTSN.DE) currently has 122 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
YTSN.DE does not pay a dividend.
KUROS BIOSCIENCES AG-REG (YTSN.DE) will report earnings on 2025-08-13.
KUROS BIOSCIENCES AG-REG (YTSN.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.11).
ChartMill assigns a technical rating of 2 / 10 to YTSN.DE.
ChartMill assigns a fundamental rating of 4 / 10 to YTSN.DE. No worries on liquidiy or solvency for YTSN.DE as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months YTSN.DE reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS increased by 69.49% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -5.07% | ||
ROE | -7.3% | ||
Debt/Equity | 0.08 |
ChartMill assigns a Buy % Consensus number of 86% to YTSN.DE. The Buy consensus is the average rating of analysts ratings from 7 analysts.